TABLE 1.
Clinical and microbiological characteristics of the KPC-producing K. pneumoniae
| Patient isolate | Age (yr) | Underlying illness | Source of isolate | Possible origin of the isolate | blaKPC type | Susceptibilityb (MIC, mg/liter) to:
|
|||
|---|---|---|---|---|---|---|---|---|---|
| Meropenem | Ertapenem | Tigecycline | Colistin | ||||||
| 1 | 87 | Stroke | Urine | NYCa | 3 | >128 | >128 | 0.5 | 0.125 |
| 2 | 87 | Alzheimer's disease | Urine | Patient 1 | 3 | >128 | >128 | 0.5 | 0.25 |
| 3 | 67 | Primary sclerosing cholangitis | Blood | Florida | 3 | 2 | >128 | 2 | 0.5 |
a
Although the patient did travel to New York City (NYC), there was no known contact with a health care facility.
b
MICs of isolates were determined by the Etest.